New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.
about
Changes in levels of angiotensin II and its receptors in a model of inverted stress-induced cardiomyopathy.Comparison of aldosterone synthesis in adrenal cells, effect of various AT1 receptor blockers with or without atrial natriuretic peptide.Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.Dual inhibitory action on aldosterone by combined angiotensin receptor antagonism and neprilysin inhibition.Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling.
P2860
New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New drug therapies interfering ...... em for resistant hypertension.
@ast
New drug therapies interfering ...... em for resistant hypertension.
@en
New drug therapies interfering ...... em for resistant hypertension.
@nl
type
label
New drug therapies interfering ...... em for resistant hypertension.
@ast
New drug therapies interfering ...... em for resistant hypertension.
@en
New drug therapies interfering ...... em for resistant hypertension.
@nl
prefLabel
New drug therapies interfering ...... em for resistant hypertension.
@ast
New drug therapies interfering ...... em for resistant hypertension.
@en
New drug therapies interfering ...... em for resistant hypertension.
@nl
P2093
P2860
P356
P1476
New drug therapies interfering ...... em for resistant hypertension.
@en
P2093
Aurélien Lorthioir
Guillaume Bobrie
Matthieu Monge
Michel Azizi
P2860
P304
P356
10.1177/1470320313513408
P577
2013-11-12T00:00:00Z